Fierce Biotech June 22, 2021
Andrea Park

In recent years, wearables and other digital devices have been increasingly used in clinical trials to track participants’ daily health data throughout a trial’s duration. Now, following the boom in decentralized, virtual studies caused by the COVID-19 pandemic, these sensor-equipped tools are practically a prerequisite for any newly launched study.

Despite this near-ubiquity, however, there are no universal standards in place to ensure devices are safe and accurate enough for widespread use in large clinical trials.

Until now, that is: HumanFirst and the Duke University School of Medicine’s Clinical Research Institute have teamed up to launch the Digital Measures Evaluation Center to help vet data collecting technologies for use in research projects.

The center will develop a set of protocols...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Wearables
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Pelago Defies Digital Health Funding Drought, Raises $58M
Digital health venture capital deals stagnate
Finger on the Pulse: The State of Primary Care in the U.S. and Nine Other Countries
Embracing digital transformation with a digital factory

Share This Article